CORZ Stock Analysis: Core Scientific, Common | NASDAQ
Software - Infrastructure | NASDAQ, USA | Market Cap: 8.646m USD | 12M Return: 52% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 335M
Qual. Beats: 0
Rev. Trend: -81.5%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 2.4 years of data
Average return per month, with how dependable it is below — did the month move the same way every year (high) or randomly (low). Above 60 is a pattern worth trusting; under 40 is noise.
Core Scientific, Inc. (NASDAQ: CORZ) is a U.S.-based digital infrastructure provider that operates across three segments: Colocation, Digital Asset Self-Mining, and Digital Asset Hosted Mining. The company supplies space, power, cooling, and operational services to third-party customers running compute-intensive workloads, including artificial intelligence and machine learning applications. In its mining segments, Core Scientific both operates its own fleet of Bitcoin miners and hosts third-party mining equipment, earning revenue through a combination of block rewards and hosting fees.
Founded in 2017 and headquartered in Dover, Delaware, Core Scientific operates data center facilities that consume large amounts of electrical power, which is a key cost driver for both colocation and crypto mining operations. The companys dual focus on AI/ML colocation and Bitcoin mining reflects a broader industry trend of repurposing power-intensive data center infrastructure to serve multiple high-density computing use cases.
- Bitcoin price swings drive mining revenue volatility
- AI colocation demand expands high-margin hosting segment
- Energy costs and power capacity pressure mining margins
| Net Income: -1.22b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.15 > 0.02 and ΔFCF/TA -4.82 > 1.0 |
| NWC/Revenue: -340.2% < 20% (prev 155.2%; Δ -495.4% < -1%) |
| CFO/TA 0.19 > 3% & CFO 568.7m > Net Income -1.22b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.55 > 1.5 & < 3 |
| Outstanding Shares: last quarter (322.9m) vs 12m ago -11.12% < -2% |
| Gross Margin: 16.72% > 18% (prev 12.57%; Δ 4.15% > 0.5%) |
| Asset Turnover: 15.11% > 50% (prev 25.28%; Δ -10.17% > 0%) |
| Interest Coverage Ratio: -37.95 > 6 (EBIT TTM -295.2m / Interest Expense TTM 7.78m) |
| A: -0.39 (Total Current Assets 1.45b - Total Current Liabilities 2.66b) / Total Assets 3.07b |
| B: -1.46 (Retained Earnings -4.49b / Total Assets 3.07b) |
| C: -0.13 (EBIT TTM -295.2m / Avg Total Assets 2.35b) |
| D: -0.30 (Book Value of Equity -1.31b / Total Liabilities 4.38b) |
| Altman-Z'' = -8.51 = D |
| DSRI: 3.0 (Receivables 315.7m/1.02m, Revenue 354.7m/410.9m) |
| GMI: 0.75 (GM 12.57% / 16.72%) |
| AQI: 2.83 (AQ_t 0.05 / AQ_t-1 0.02) |
| SGI: 0.86 (Revenue 354.7m / 410.9m) |
| TATA: -0.58 (NI -1.22b - CFO 568.7m) / TA 3.07b) |
| Beneish M = -0.68 (Cap -4..+1) = D |
As of June 30, 2026, the stock is trading at USD 25.94 with a total of 10,277,442 shares traded. Over the past week, the price has changed by -10.80%, over one month by -3.39%, over three months by +86.48% and over the past year by +51.96%.
Current recommended Stop Loss: 23.10 (which is 10.9% or 1.6 ATR below the current price).
Core Scientific, Common has received a consensus analysts rating of 4.69. Therefore, it is recommended to buy CORZ.
- StrongBuy: 12
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 32.9 | 26.7% |
P/E Forward = 166.6667
P/S = 24.3743
Revenue TTM = 354.7m USD
EBIT TTM = -295.2m USD
EBITDA TTM = -229.0m USD
Long Term Debt = 1.06b USD (from longTermDebt, last quarter)
Short Term Debt = 993.9m USD (from shortTermDebt, last quarter)
Debt = 2.16b USD (from shortLongTermDebtTotal, last quarter) + Leases 102.2m
Net Debt = 1.15b USD (calculated: Debt 2.16b - CCE 1.01b)
Enterprise Value = 9.80b USD (8.65b + Debt 2.16b - CCE 1.01b)
Interest Coverage Ratio = -37.95 (Ebit TTM -295.2m / Interest Expense TTM 7.78m)
EV/FCF = -20.80x (Enterprise Value 9.80b / FCF TTM -471.2m)
FCF Yield = -4.81% (FCF TTM -471.2m / Enterprise Value 9.80b)
FCF Margin = -132.8% (FCF TTM -471.2m / Revenue TTM 354.7m)
Net Margin = -342.9% (Net Income TTM -1.22b / Revenue TTM 354.7m)
Gross Margin = 16.72% ((Revenue TTM 354.7m - Cost of Revenue TTM 295.4m) / Revenue TTM)
Gross Margin QoQ = 25.81% (prev 26.02%)
Tobins Q-Ratio = 3.19 (Enterprise Value 9.80b / Total Assets 3.07b)
Interest Expense / Debt = 0.36% (Interest Expense 7.78m / Debt 2.16b)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -233.2m (EBIT -295.2m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.55 (Total Current Assets 1.45b / Total Current Liabilities 2.66b)
Debt / Equity = -1.65 (negative equity) (Debt 2.16b / totalStockholderEquity, last quarter -1.31b)
Debt / EBITDA = -5.03 (negative EBITDA) (Net Debt 1.15b / EBITDA -229.0m)
Debt / FCF = -2.45 (negative FCF - burning cash) (Net Debt 1.15b / FCF TTM -471.2m)
Total Stockholder Equity = -1.12b (last 4 quarters mean from totalStockholderEquity)
RoA = -51.82% (Net Income -1.22b / Total Assets 3.07b)
RoE = 109.1% (negative equity) (Net Income TTM -1.22b / Total Stockholder Equity -1.12b)
RoCE = 550.6% (negative capital employed) (EBIT -295.2m / Capital Employed (Equity -1.12b + L.T.Debt 1.06b))
RoIC = -16.85% (negative operating profit) (NOPAT -233.2m / Invested Capital 1.38b)
WACC = 12.65% (E(8.65b)/V(10.8b) * Re(15.74%) + D(2.16b)/V(10.8b) * Rd(0.36%) * (1-Tc(0.21)))
Discount Rate = 15.74% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 68.89 | Cagr: 37.03%
[DCF] Fair Price = unknown (Cash Flow -471.2m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.67 | # QB: 0
Revenue Correlation: -81.53 | Revenue CAGR: -18.34% | SUE: 0.28 | # QB: 0
EPS next Quarter (2026-09-30): EPS=-0.06 | Chg30d=+0.00% | Revisions=+0% | Analysts=2
EPS current Year (2026-12-31): EPS=-1.04 | Chg30d=+10.34% | Revisions=-20% | GrowthEPS=-70.5% | GrowthRev=+94.3%
EPS next Year (2027-12-31): EPS=0.30 | Chg30d=-5.81% | Revisions=+0% | GrowthEPS=+128.5% | GrowthRev=+71.2%
[Analyst] Revisions Ratio: -20%